Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
  1. 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 4,147 shares (to pay taxes)
  2. 4 Shares withheld for taxes President and CEO gave up 6,528 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 4,911 shares (to pay taxes)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4/A Gift Executive Vice Chair gave 52,208 shares (gift)
  11. 4 Derivatives Options or other derivatives
  12. 4 Planned sale Chief Medical Officer sold 1,458 shares at $20.00 ($29,160)
  13. 4 Open-market buy 10% owner bought 588,235 shares at $17.00 ($9,999,995)
  14. 4/A Planned sale Chief Corp Dev.&Strat. Officer sold 46,000 shares at an average $21.97 ($1,010,790)
  15. 4 Open-market sale Director sold 1,000,000 shares at an average $19.51 ($19,510,637)
  16. 4 Open-market sale Director sold 1,000,000 shares at an average $19.51 ($19,510,637)
  17. 4 Planned sale Chief Corp Dev.&Strat. Officer sold 45,000 shares at $22.00 ($990,000)
  18. 4 Planned sale Chief Medical Officer sold 30,625 shares at $22.00 ($673,750)
  19. 4 Planned sale Executive Vice Chair sold 20,000 shares at $20.76 ($415,200)
  20. 4 Open-market buy 10% owner bought 1,919,057 shares at an average $21.82 ($41,874,151)

Page 6 of 23 · 459 filings